ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.266,90
0,28%
S&P 500
5.943,73
-0,53%
Dow Jones
42.688,34
-0,04%
Euro vs US Dollar
1,03688
-0,14%
Bitcoin
98.071,34
-4,12%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. GeoVax Labs Inc (GOVX) Börsenkurse

GeoVax Labs Inc

GeoVax Labs Inc (GOVX)

NASDAQ
2,46
-0,14
( -5,38% )
Aktualisiert: 16:39:37
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2,46
Gebot
2,46
Fragen
2,47
Volumen
319.707
2,46 Tagesbereich 2,6199
1,0901 52-Wochen-Bereich 11,18
Marktkapitalisierung
23,213M
Handelsende
2,60
Handelsbeginn
2,5789
Letzte Trade
4
@
2.465
Letzter Handelszeitpunkt
16:39:37
Finanzvolumen
US$ 810.998
VWAP
2,5367
Durchschnittliches Volumen (3 Mio.)
1.757.415
Ausgegebene Aktien
9.436.069
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,94
Gewinn pro Aktie (EPS)
-2,75
Erlöse
-
Nettogewinn
-25,97M

Über GeoVax Labs Inc

Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.geovax.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
GeoVax Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOVX. The last closing price for GeoVax Labs was US$2,60. Over the last year, GeoVax Labs shares have traded in a share price range of US$ 1,0901 to US$ 11,18.

GeoVax Labs currently has 9.436.069 shares in issue. The market capitalisation of GeoVax Labs is US$24,53 million. GeoVax Labs has a price to earnings ratio (PE ratio) of -0.94.

GOVX Neueste Nachrichten

Weitere Nachrichten

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies...

09 Dezember 2024
GlobeNewswire Inc.

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that...

26 November 2024
GlobeNewswire Inc.

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GEO-CM04S1 Improved Immune Response vs mRNA Vaccine ATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and...

19 November 2024
GlobeNewswire Inc.

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance...

12 November 2024
GlobeNewswire Inc.

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against...

05 November 2024
GlobeNewswire Inc.

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced...

02 Oktober 2024
GlobeNewswire Inc.

GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...

03 September 2024
GlobeNewswire Inc.

Form 8-K - Current report

30 August 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

30 August 2024
Edgar (US Regulatory)

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...

29 August 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.020.8196721311482.442.752.38511149522.5432137CS
4-0.16-6.106870229012.622.752.137154182.40193069CS
120.4522.38805970152.013.881.7517574152.84113355CS
26-0.24-8.888888888892.711.181.631544225.17949865CS
52-3.09-55.67567567575.5511.181.090122612874.52567115CS
156-50.94-95.39325842753.464.51.0901373062725.31410439CS
260-42.54-94.533333333345130.651.0901304312132.35060095CS

GOVX - Frequently Asked Questions (FAQ)

What is the current GeoVax Labs share price?
The current share price of GeoVax Labs is US$ 2,46
How many GeoVax Labs shares are in issue?
GeoVax Labs has 9.436.069 shares in issue
What is the market cap of GeoVax Labs?
The market capitalisation of GeoVax Labs is USD 24,53M
What is the 1 year trading range for GeoVax Labs share price?
GeoVax Labs has traded in the range of US$ 1,0901 to US$ 11,18 during the past year
What is the PE ratio of GeoVax Labs?
The price to earnings ratio of GeoVax Labs is -0,94
What is the reporting currency for GeoVax Labs?
GeoVax Labs reports financial results in USD
What is the latest annual profit for GeoVax Labs?
The latest annual profit of GeoVax Labs is USD -25,97M
What is the registered address of GeoVax Labs?
The registered address for GeoVax Labs is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the GeoVax Labs website address?
The website address for GeoVax Labs is www.geovax.com
Which industry sector does GeoVax Labs operate in?
GeoVax Labs operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HOTHHoth Therapeutics Inc
US$ 2,61
(218,45%)
195,15M
RIMEAlgorhythm Holdings Inc
US$ 0,2564
(77,07%)
527,32M
XTIAXTI Aerospace Inc
US$ 0,1458
(65,68%)
1,48B
DATSDatChat Inc
US$ 3,058
(56,02%)
18,84M
SVMHSRIVARU Holding Ltd
US$ 0,067
(44,71%)
326,81M
SLRNACELYRIN Inc
US$ 2,19
(-37,25%)
6,81M
DHAIDIH Holdings US Inc
US$ 1,9101
(-34,59%)
1M
BOXLBoxlight Corporation
US$ 1,1409
(-32,09%)
4,1M
AMSTAmesite Inc
US$ 2,85
(-29,63%)
388,63k
COEPCoeptis Therapeutics Holdings Inc
US$ 4,98
(-28,96%)
566,03k
XTIAXTI Aerospace Inc
US$ 0,1436
(63,18%)
1,45B
RIMEAlgorhythm Holdings Inc
US$ 0,2531
(74,79%)
522,11M
SVMHSRIVARU Holding Ltd
US$ 0,06685
(44,38%)
322,53M
HOTHHoth Therapeutics Inc
US$ 2,75
(235,53%)
193,36M
CDTConduit Pharmaceuticals Inc
US$ 0,096
(32,78%)
143,27M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
GOVX
GeoVax Labs
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten